BrainFx and Maple Announce Partnership To Expand Canadians’ Access To Cognitive Functional Assessments For Neurofunctional Health
BrainFx partners with Maple

October 30, 2020 — BrainFx, a leading digital cognitive functional assessment platform, and Maple, Canada’s leading virtual care provider, have entered into a partnership to expand Canadians’ access to cognitive functional assessments for neurofunctional health.

The COVID-19 pandemic has disrupted traditional models of care and accelerated the shift towards greater accessibility and convenience through virtual care delivery. The pandemic has also impacted the health and wellness of Canadians, particularly as it relates to neurofunctional health. Neurological conditions such as Traumatic Brain Injuries (TBI) and Alzheimer’s continue to be meaningful issues for Canadians; and both COVID-19 and changes to daily life such as increased social isolation have emerged as new and growing areas of challenge from a neurological perspective.

BrainFx and Maple have committed to ensuring that Canadians can continue to get timely, convenient and reliable access to high-quality, evidence-based clinical assessments of cognitive function during this time. By integrating these innovative technologies, Canadians can easily connect online to allied health professionals to continue to get much needed assessments and care, and empowers them to both better understand and track their neurofunctional health.

For more information on BrainFx, visit

To learn more about Maple, visit

About Maple

Maple is a technology platform that tackles some of the world’s most meaningful issues in healthcare, starting with timely and convenient access to doctors and other healthcare providers including dermatologists, psychiatrists, and oncology navigation experts. It allows patients to connect directly with doctors and specialists for medical care in minutes from their smartphone or computer 24/7, and also provides custom technology solutions for employers, insurers, hospitals, and clinics. Learn more at

About BrainFx

BrainFx develops digital, neurofunctional assessments tools to detect the milder forms of cognitive dysfunction that other tests can miss. BrainFx’s mission is to improve the quality of life of those living with brain disorders globally by making the invisible effects of brain disorders visible. By combining research with technology and clinical knowledge, BrainFx assessments deliver unique insights to health care teams across the continuum of care and help answer ‘What Next?’ to make a difference in health outcomes. For more information, visit

Interested in working with us?

Get in touch with us below to learn more

Let's make the INVISIBLE effects of brain disorders VISIBLE, together.

BrainFx logo

Copyright © 2022 - BrainFx. All rights reserved.

Important Information: BrainFx Assessments only provide information about neurofunctional performance. Assessment results detail the patient/client's performance on assessment activities completed and only assist the health care team in identifying potential areas of strength or challenge as related to function. Assessments DO NOT provide any diagnosis or treatment recommendations. BrainFx Assessments are only permitted to be delivered by trained clinicians. Assessment reports are not stand-alone and require the interpretation of a health professional within their scope of practice and in the context of all information that they have gathered about their patient/client. In Canada, BrainFx Assessments are cleared by Health Canada as a Class 1 Software as a Medical Device. BrainFx Assessments and the statements made on this website have not been evaluated by any other regulatory bodies. Assessments are not intended to diagnose, treat, cure, or prevent any disease. Information provided by BrainFx is not a substitute for face-to-face consultation with your health care professional and should not be construed as individual medical advice.